Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinoma

Oncology Letters

Volumn 7, Issue 2, 2014, Pages 507-512

  Zhou, Fei ^a   Mu, Yin Dong ^b   Liang, Jun ^b   Liu, Zhi Xin ^b   Chen, Hong Sheng ^c   Zhang, Ji Fei ^b  

^a Qiqihar City Hospital of Traditional Chinese Medicine   (China)

^b MUDANJIANG MEDICAL UNIVERSITY   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

ALDH1; Cancer stem cell; CD133; Colorectal carcinoma; Immunohistochemistry; Stem cell

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD133 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CELL DIFFERENTIATION; COLORECTAL CARCINOMA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PROTEIN EXPRESSION; SURVIVAL TIME;

EID: 84890350906     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1723     Document Type: Article

References (25)

1. Center MM, Jemal A and Ward E: International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev18: 1688-1694, 2009.
2. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin60: 277-300, 2010.
3. Peppone LJ, Mahoney MC, Cummings KM, Michalek AM, Reid ME, Moysich KB and Hyland A: Colorectal cancer earlier in those exposed to tobacco smoke: implication for screening. J Cancer Res Clin Oncol134: 743-751, 2008.
4. Hamburger AW and Salmon SE: Primary bioassay of human tumor stem cells. Science197: 461-463, 1977.
5. Boman BM and Wicha MS: Cancer stem cells: a step toward the cure. J Clin Oncol26: 2795-2799, 2008.
6. Abdul Khalek FJ, Gallicano GI and Mishra L: Colon cancer stem cells. Gastrointest Cancer ResNov (Suppl 1): S16-S23, 2010.
7. Sophos NA and Vasiliou V: Aldehyde dehydrogenase gene superfamily: the 2002 update. Chem Biol Interact143-144: 5-22, 2003.
8. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, et al: Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res69: 3382-3389, 2009.
9. Patel M, Lu L, Zander DS, Sreerama L, Coco D and MorebJS: ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors. Lung Cancer59: 340-349, 2008.
10. Nogami T, Shien T, Tanaka T, Nishiyama K, Mizoo T, IwamtoT, et al: Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1-3 lymph node metastases. Breast Cancer: Mar10, 2012 (Epub ahead of print).
11. Corbeil D, Roper K, Hellwig A, Tavian M, Miraglia S, WattSM, etal: The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem275: 5512-5520, 2000.
12. Singh, SK, Hawkins C, Clarke ID, Squire JA, Bayani J, HideT, etal: Identification of human brain tumor initiating cells. Nature432: 396-401, 2004.
13. Collins AT, Berry PA, Hyde C, Stower MJ and Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res65: 10946-10951, 2005.
14. Yin S, Li J, Hu C, Chen X, Yao M, Yan M, et al: CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer120: 1444-1450, 2007.
15. Hermann PC, Huber SI, Herrler T, Aicher A, Ellwart JW, GubaM, et al: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell1: 313-323, 2007.
16. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di VirgilioA, etal: Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ15: 504-514, 2008.
17. O'Brien CA, Pollett A, Gallinger S and Dick JE: A human colon cancer cell capable of initiating tumor growth in immunodeficient mice. Nature445: 106-110, 2007.
18. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, TodaroM, Peschle C and De Maria R: Identification and expansion of human colon-cancer-initiating cells. Nature445: 111-115, 2007.
19. Todaro M, Alea MP, Di Stefano AB, Cammareri P, VermeulenL, Lovino F, et al: Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell1: 389-402, 2007.
20. Ieta K, Tanaka F, Haraguchi N, Kita Y, Sakashita H, MimoriK, etal: Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann Surg Oncol15: 638-648, 2008.
21. Horst D, Kriegl L, Engel J, Kirchner T and Jung A: CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer99: 1285-1289, 2008.
22. Zhang T, Otevrel T, Gao Z, Gao Z, Ehrlich SM, Fields JZ and Boman BM: Evidence that APC regulates surviving expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res61: 8664-8667, 2001.
23. Boman BM, Walters R, Fields JZ, Kovatich AJ, Zhang T, IsenbergGA, et al: Colonic crypt changes during adenoma development in familial adenomatous polyposis: immunohistochemical evidence for expansion of the crypt base cell population. Am J Pathol165: 1489-1498, 2004.
24. Horst D, Sheel SK, Liebmann S, Neumann J, Maatz S, KirchnerT and Jung A: The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer. J Pathol219: 427-434, 2009.
25. + and CD133-metastatic colon cancer cells initiate tumors. J Clin Invest 118: 2111-2120, 2008.